Biora Therapeutics (NASDAQ:BIOR) Stock Price Down 14.2% – Time to Sell?

Biora Therapeutics, Inc. (NASDAQ:BIOR) shares were down 14.2% during trading on Monday . The company traded as low as $0.15 and last traded at $0.16. Approximately 5,826 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 58,319 shares. The stock had previously closed at $0.19.

Analysts Set New Price Targets

Separately, HC Wainwright raised their price objective on shares of Biora Therapeutics from $15.00 to $23.00 and gave the stock a “buy” rating in a report on Monday, November 18th.

Biora Therapeutics Stock Performance

The firm has a market capitalization of $737,249.00, a P/E ratio of -0.01 and a beta of 1.12. The business has a fifty day moving average of $0.94 and a 200-day moving average of $4.09.

Biora Therapeutics Company Profile

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.